[New therapeutic contribution in proctology: esberiven].
D000328:Adult; D000368:Aged; D000893:Anti-Inflammatory Agents / Q000009:adverse effects / Q000627:therapeutic use*; D001004:Anus Diseases / Q000188:drug therapy*; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010936:Plant Extracts / Q000009:adverse effects / Q000627:therapeutic use*; D012002:Rectal Diseases / Q000188:drug therapy*
D000893:Anti-Inflammatory Agents; D010936:Plant Extracts
Nouvel apport therapeutique en proctologie: l'esberiven